The FDA has recalled multiple lots of a blood pressure medication sold under the brand name Ziac, according to a Dec. 6 report from USA Today.
The medication — bisoprolol fumarate and hydrochlorothiazide tablets — is manufactured by Glenmark Pharmaceuticals and may have been cross-contaminated with cholesterol drug ezetimibe, the report said.
The Class III recall affects 2.5-mg to 6.25-mg dosages from the following lots, according to USA Today:
- 30-tablet bottles, NDC-68462-878-30. Lot 17232401, exp. 11/2025.
- 100-tablet bottles, NDC-68462-878-01. Lot 17232401, exp. 11/2025.
- 500-tablet bottles, NDC-68462-878-05. Lot 17232401, exp. 11/2025
- 500-tablet bottles, NDC-68462-878-05. Lot 17240974, exp. 05/2026.
